Promise of new translational safety biomarkers in drug development and challenges to regulatory qualification
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promise of new translational safety biomarkers in drug development and challenges to regulatory qualification
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 5, Issue 4, Pages 497-514
Publisher
Future Medicine Ltd
Online
2011-08-24
DOI
10.2217/bmm.11.52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension
- (2010) Dalia Urboniene et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A Systematic Approach to Preclinical and Clinical Safety Biomarker Qualification Incorporating Bradford Hill's Principles of Causality Association
- (2010) R K Chetty et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
- (2010) J A DiMasi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Research at the interface of industry, academia and regulatory science
- (2010) William B Mattes et al. NATURE BIOTECHNOLOGY
- Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury
- (2010) Yan Yu et al. NATURE BIOTECHNOLOGY
- Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury
- (2010) Frank Dieterle et al. NATURE BIOTECHNOLOGY
- Next-generation biomarkers for detecting kidney toxicity
- (2010) Joseph V Bonventre et al. NATURE BIOTECHNOLOGY
- Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
- (2010) Frank Dieterle et al. NATURE BIOTECHNOLOGY
- Towards consensus practices to qualify safety biomarkers for use in early drug development
- (2010) Frank D Sistare et al. NATURE BIOTECHNOLOGY
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
- (2010) Vishal S Vaidya et al. NATURE BIOTECHNOLOGY
- EU Framework 6 Project: Predictive Toxicology (PredTox)—overview and outcome
- (2010) Laura Suter et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury
- (2009) O. F. Laterza et al. CLINICAL CHEMISTRY
- Circulating microRNAs, potential biomarkers for drug-induced liver injury
- (2009) K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Electrochemiluminescent immunoassay for rat skeletal troponin I (Tnni2) in serum
- (2009) Deqin Sun et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The carcinoGENOMICS project: Critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays
- (2008) M VINKEN et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development
- (2007) John A. Wagner Annual Review of Pharmacology and Toxicology
- Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity
- (2007) Peter James O’Brien TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started